Want to see ATEC full AI Analyst Report?
Earnings Data
Report Date
Jul 30, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.07Last Year’s EPS
0.02Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a largely constructive operational and financial picture: healthy top-line growth (14% total, 17% surgical), strong surgeon and case adoption (23% and 21%), margin expansion, and substantial adjusted EBITDA improvement (97% YoY). Key near-term execution challenges center on EOS system deliveries and installation timing, mix-driven revenue-per-case pressure, and temporary working-capital investments (inventory/instruments). Management updated EOS near-term expectations but maintained surgical and adjusted EBITDA guidance, emphasized corrective actions (sales/marketing/support hires), and closed a favorable refinancing to improve the capital structure. On balance, the positive scale, profitability, and strategic momentum outweigh the execution-related headwinds noted for the quarter.Company Guidance
Top-line Revenue Growth
Total Q1 revenue of $192M, up 14% year over year; surgical revenue $178M, up 17% year over year.
Strong Procedural and Surgeon Adoption
Cases increased 21% year over year and new surgeon users grew 23% year over year, indicating durable adoption and volume-led growth.
Adjusted EBITDA and Profitability Expansion
Adjusted EBITDA of $21M in Q1 (11% of revenue), up 97% year over year; company reports ~45% drop-through on incremental revenue and trailing twelve-month EBITDA now >$100M.
Gross Margin and Operating Leverage
Gross margin 71.6%, improved by over 120 basis points year over year; operating expenses grew ~6% year over year, below revenue growth, demonstrating operating leverage.
Procedure-Level ASP Strength
Core procedural ASPs showed strength: lateral +2% YoY, ALIF +4% YoY, cervical +8% YoY.
Cash Position and Cash Flow
Ending cash approximately $140M; positive operating cash flow for the fourth consecutive quarter; free cash used ~$11M in Q1 (within expected range) and full-year free cash flow guidance of at least $20M.
Strategic Financing Improvement
Closed new Term Loan A and revolving credit facility that extends maturities to 2031, reduces interest expense by >$6M annually and is estimated to save up to ~$35M in interest over the facility life (rate SOFR + 275 bps).
EOS Platform Traction and Installed Base Growth
Installed base of global EOS units increased 7% YoY; EOS Edge installed base grew 39% YoY; EOS Insight accounts more than doubled and EOS Insight adoption shows meaningful implant pull-through and ~30% revenue lift per surgeon after adoption.
ATEC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ATEC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $10.23 | $6.99 | -31.67% |
Feb 24, 2026 | $13.93 | $14.04 | +0.79% |
Oct 30, 2025 | $16.33 | $18.99 | +16.29% |
Jul 31, 2025 | $10.58 | $13.77 | +30.15% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Alphatec (ATEC) report earnings?
Alphatec (ATEC) is schdueled to report earning on Jul 30, 2026, After Close (Confirmed).
What is Alphatec (ATEC) earnings time?
Alphatec (ATEC) earnings time is at Jul 30, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ATEC EPS forecast?
ATEC EPS forecast for the fiscal quarter 2026 (Q2) is 0.07.